AAA September 2015 – Page 17

WuXi PharmaTech helps pump $42m into Ivenix

US-based medical device maker Ivenix closed a $42m series D round led by healthcare research and development services company WuXi PharmaTech’s corporate venturing unit, WuXi Healthcare Ventures, on Tuesday. The round also featured venture capital partnership Cardinal Partners, asset manager Cica, investment firm Easterly Capital, VC firm SCP Vitalife Partners and Fidelity Biosciences, a division… Continue reading WuXi PharmaTech helps pump $42m into Ivenix

Comstock’s GE rise is venturing endorsement

Beth Comstock’s promotion at GE to become its first female vice chair is one of the latest signs that venturing and digital innovation is being taken extremely seriously at the top of corporate America and globally.  Comstock has become one of the poster children for corporate innovation through her championing of the Lean Startup methodology at… Continue reading Comstock’s GE rise is venturing endorsement

Mobcrush rallies investors for $11m series A

Mobcrush, a US-based live streaming platform for mobile games backed by a range of corporate investors, raised $11m in a series A round led by venture capital firm Kleiner Perkins Caufield & Byers (KPCB) yesterday. VC firms First Round Capital, Lowercase, Rincon Venture Partners, Crosscut Ventures and Advancit Capital, as well as Raine Ventures, the… Continue reading Mobcrush rallies investors for $11m series A

Intellia assembles $70m series B

Intellia Therapeutics, a US-based company specialising in gene-editing, closed a $70m series B round yesterday featuring pharmaceutical firm Novartis. The round was led by OrbiMed Healthcare Fund Management and featured financial services conglomerate Fidelity Management and Research Company, Janus Capital Management, Foresite Capital, Sectoral Asset Management, EcoR1 Capital, Atlas Venture and a range of unnamed… Continue reading Intellia assembles $70m series B